Program 2026
Thursday, May 7, 2026
| 09.45-10.00h | Welcome and Introduction | |
|---|---|---|
| Nuclear Medicine meets Neuro-Oncology. | Nathalie L. Albert (Munich), Matthias Preusser (Vienna) |
| 10.00-11.00h | Opening Keynote Lecture | |
|---|---|---|
| Chairs: Michael Weller (Zurich), Timothy Cloughesy (Los Angeles) | ||
| Designing definitive clinical trials for novel therapies in brain tumors. | Elizabeth Eisenhauer (Kingston) |
| 11.00-12.00h | Understanding PET RANO criteria | |
|---|---|---|
| Chairs: Patrick Wen (Boston), Ben Ellingson (Los Angeles) | ||
| PET RANO in clinical trials: from conception to endpoint. | Matthias Preusser (Vienna) | |
| PET RANO in action: from guidelines to clinical cases. | Nathalie Albert (Munich) | |
| PET RANO response as primary endpoint? | Panel discussion: Franceso Pignatti (EMA), Elizabeth Eisenhauer (Kingston) |
| 12.00-13.00h | NMN Lunch |
|---|
| 13.00-14.30h | Clinical trials in the (hot)spotlight | |
|---|---|---|
| Chairs: Roberta Ruda (Turin), Ingo Mellinghoff (New York) | ||
| Theranostics in neuro-oncology: current clinical trial landscape. | Erik Sulman (Durham) | |
| The heat is on: clinical trials in focus. | ||
| The IPAX trial series. | Nelleke Tolboom (Utrecht) | |
| LUMEN-1 and MOMENTUM-1. | Eng-Siew Koh (Sydney) |
| 14.30-15.30h | Proffered papers I: Hot data and burning questions | |
|---|---|---|
| Chairs: Emilie Le Rhun (Zurich), Marcus Hacker (Vienna) | ||
| Oral presentations from selected abstracts | ||
| 15.30-16.30h | NMN Poster viewing with Coffee and Cake |
|---|
| 16.30-17.30h | Proffered papers II: Hot data and burning questions | |
|---|---|---|
| Chairs: Norbert Galldiks (Cologne), Antoine Verger (Nancy) | ||
| Oral presentations from selected abstracts | ||
| From 19.00h | Networking Event |
|---|
Friday, May 8, 2026
| 09.00-10.00 | NMN Networking Coffee | |
|---|---|---|
Meet and greet:
|
| 10.00-12.00h | Innovations and controversies in theranostics | |
|---|---|---|
| Chairs: Wim Oyen (Milan / Arnhem), Jana Ivanidze (New York) | ||
| #increasingthepower – the rise of alpha emitters. | Wolfgang Wadsak (Vienna) | |
| #bettertogether – the potential of combination therapies. | Ken Herrmann (Essen) | |
| #theradosetics – the concept of precision dosing in theranostics. | Christophe Deroose (Leuven) | |
| #crossingthebarrier – the role of focused ultrasound and BBB transport. | Roger Stupp (Chicago) |
| 12.00-13.00h | NMN Lunch |
|---|
| 13.00-14.30h | NMN casting: theranostic targets for brain tumors – top or flop? | |
|---|---|---|
| Chairs: Evanthia Galanis (Rochester), Rakesh Jalali (Chennai)
Jury: Jolanta Kunikowska (Warsaw), Felix Sahm (Heidelberg), Francesco Cicone (Catanzaro) |
||
| EGFR | Andrew Scott (Melbourne) | |
| PSMA | Sophie Veldhuijzen van Zanten (Rotterdam) | |
| SSTR | Christophe Deroose (Leuven) | |
| FAP | Ken Herrmann (Essen) | |
| LAT1 | Jan Werner (Cologne) | |
| CA IX / XII | Maximilian Mair (Vienna) | |
| Discussion | (all) | |
| 14.30-15.15h | NMN Coffee |
|---|
| 15.15-16.45h | Amino acid PET for glioma imaging – toy or tool in clinical practice? | |
|---|---|---|
| Chairs: Ian Law (Copenhagen), Giuseppe Minniti (Rome) | ||
| A global perspective on PET imaging in neuro-oncology. | Andrew Scott (Melbourne) | |
| PET for surgery planning is just a toy! | Gelareh Zadeh (Rochester) | |
| PET for surgery planning is an indispensable tool! | Jörg-Christian Tonn (Munich) | |
|
||
| PET for radiotherapy planning is just a toy! | Stephanie Combs (Munich) | |
| PET for radiotherapy planning is an indispensable tool! | Maximilian Niyazi (Tübingen) | |
|
||
| PET for follow-up is just a toy! | Martin van den Bent (Rotterdam) | |
| PET for follow-up is an indispensable tool! | Anna Berghoff (Vienna) | |
|
| 16.45-17.00h | Conclusions and Farewell Drinks | |
|---|---|---|
| Nathalie L. Albert (Munich), Matthias Preusser (Vienna) |
